The proposed shift of KP metabolism away from kynurenic acid in conditions such as schizophrenia and major depression may encourage glutamate-induced toxicity to develop in their chronic stages, partly due to compensatory glutamate release or receptor up-regulation. The gene discussed is NPPA; the disease is schizophrenia.